Medicine and Dentistry
Patient
100%
Etanercept
54%
Adverse Event
16%
Psoriasis
16%
Infection
12%
Psoriasis Area and Severity Index
12%
Therapeutic Procedure
12%
Combination Therapy
4%
Antibody
4%
Psoriasis Vulgaris
4%
Dermatology Life Quality Index
4%
Assessment
4%
Amaurosis
4%
Nursing and Health Professions
Etanercept
54%
Placebo
25%
Adverse Event
16%
Psoriasis
16%
Inpatient
16%
Infection
12%
Psoriasis Area and Severity Index
12%
Adult
8%
Physician
4%
Antibody
4%
Combination Therapy
4%
Dermatology Life Quality Index
4%
Psoriasis Vulgaris
4%
Blindness
4%
INIS
patients
58%
psoriasis
33%
safety
12%
design
4%
assessments
4%
therapy
4%
adults
4%
medical centers
4%
interventions
4%
usa
4%
antibodies
4%
canada
4%
Pharmacology, Toxicology and Pharmaceutical Science
Etanercept
54%
Adverse Event
16%
Psoriasis
16%
Infection
12%
Psoriasis Vulgaris
4%
Antibody
4%
Blindness
4%